Literature DB >> 15334879

Influence of paroxysmal atrial fibrillation attack on brain natriuretic peptide secretion.

Keizo Tsuchida1, Kazuhiko Tanabe.   

Abstract

OBJECTIVES: Plasma brain natriuretic peptide (BNP) concentration is higher during atrial fibrillation (Af) than sinus rhythm, based on studies of electrical defibrillation treatment of patients with chronic Af. However, the change in paroxysmal atrial fibrillation (PAf) is not well known. This study investigated such changes and the relationship between BNP and Af.
METHODS: BNP levels were successfully measured at three time points: before Af attack, during Af attack, and after (spontaneous or pharmacological) termination of 68 consecutive Af attacks in 35 outpatients with PAf (23 men, 12 women, mean age 70.4 +/- 9.6 years). BNP was measured by immunoradiometric assay.
RESULTS: BNP (median[quartiles]) during PAf was increased by 66[25, 120] pg/ml (2.4-fold) compared to during sinus rhythm (p < 0.0001), and fell to the former level after return to sinus rhythm (before attack = 39[18, 70], during attack = 102[52, 205], after attack = 35[20, 67]). BNP increased in 55 (81%) of 68 attacks, did not change (within +/- 20 pg/ml) in 11 (16%), and decreased in 2 (3%). BNP was already elevated immediately (within 4 hr) after onset of Af, and BNP elevation (delta BNP) showed no significant relationship with the time elapsed after onset. During the Af attack, 41% of PAf patients were asymptomatic although BNP increased significantly.
CONCLUSIONS: These results suggest that elevated amounts of BNP during Af are released from secretory granules in the atrium, and BNP elevation of unknown cause may be attributed to the presence of asymptomatic Af. Cardiac function evaluation using BNP during Af requires special consideration, unlike during sinus rhythm, even in patients with PAf or chronic Af, because BNP during Af is the sum of the BNP values from the ventricle (reflecting left ventricular function) and the atrium (due to Af).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15334879

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  10 in total

Review 1.  Paroxysmal Atrial Fibrillation: Novel Strategies for Monitoring and Implications for Treatment in Stroke.

Authors:  Scott B Silverman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-08

2.  Atrial fibrillation is an independent determinant of increased NT-proBNP levels in outpatients with signs and symptoms of heart failure.

Authors:  Borut Jug; Miran Sebestjen; Miso Sabovic; Maja Pohar; Irena Keber
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

3.  Steady-state B-type natriuretic peptide levels in patients with atrial fibrillation of various clinical backgrounds.

Authors:  Tsuneaki Sadanaga; Hideo Mitamura; Shun Kohsaka; Satoshi Ogawa
Journal:  Heart Vessels       Date:  2011-05-17       Impact factor: 2.037

4.  B-type natriuretic peptide levels in patients with paroxysmal lone atrial fibrillation.

Authors:  Jingtian Li; Lexin Wang
Journal:  Heart Vessels       Date:  2006-05       Impact factor: 2.037

5.  Elevated brain natriuretic peptide level in patients undergoing atrial fibrillation ablation: is it a predictor of failed ablation or a mere function of atrial rhythm and rate at a point in time?

Authors:  Jayasree Pillarisetti; Namratha Reddy; Mazda Biria; Kay Ryschon; Darbhamulla Nagarajan; Caroline Murray; Donita Atkins; Sudharani Bommana; Madhu Yeruva Reddy; Luigi DiBiase; Rhea Pimentel; Loren Berenbom; Buddhadeb Dawn; Andrea Natale; Dhanunjaya Lakkireddy
Journal:  J Interv Card Electrophysiol       Date:  2014-05-08       Impact factor: 1.900

6.  Incremental predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide for short-term recurrence in atrial fibrillation ablation.

Authors:  Hye Jin Hwang; Jung Woo Son; Byung-Ho Nam; Boyoung Joung; Byungho Lee; Jin-Bae Kim; Moon-Hyoung Lee; Yangsoo Jang; Namsik Chung; Won-Heum Shim; Seung-Yun Cho; Sung Soon Kim
Journal:  Clin Res Cardiol       Date:  2009-02-19       Impact factor: 5.460

7.  NT-proBNP is associated with mortality and adverse cardiac events in patients with atrial fibrillation presenting to the emergency department.

Authors:  Marijn J Holl; Ewout J van den Bos; Ron T van Domburg; Michael A Fouraux; Marcel J Kofflard
Journal:  Clin Cardiol       Date:  2018-02-26       Impact factor: 2.882

8.  NT -pro BNP as a Mediator of the Racial Difference in Incident Atrial Fibrillation and Heart Failure.

Authors:  Isaac R Whitman; Eric Vittinghoff; Christopher R DeFilippi; John S Gottdiener; Alvaro Alonso; Bruce M Psaty; Susan R Heckbert; Ron C Hoogeveen; Dan E Arking; Elizabeth Selvin; Lin Y Chen; Thomas A Dewland; Gregory M Marcus
Journal:  J Am Heart Assoc       Date:  2019-04-02       Impact factor: 5.501

9.  Cardiac biomarkers in acute respiratory distress syndrome: a systematic review and meta-analysis.

Authors:  Dilip Jayasimhan; Simon Foster; Catherina L Chang; Robert J Hancox
Journal:  J Intensive Care       Date:  2021-04-26

10.  N-terminal pro-brain natriuretic peptide and atrial fibrillation.

Authors:  Jayachandran Thejus; Johnson Francis
Journal:  Indian Pacing Electrophysiol J       Date:  2009-01-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.